SCHEMBL9562306

SCHEMBL9562306

O=C1CCc2cc(C(O)CN3CCC(C4(c5ccc(F)cc5)OCCO4)CC3)ccc2N1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 9/20 0.57
GRIN2B Q13224 3/20 0.47
KDM4E B2RXH2 2/20 0.40
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
ALDH1A1 P00352 2/20 0.38
ATM Q13315 1/20 0.38
TSHR P16473 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
GMNN O75496 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
GRIN1 Q05586 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9768325 0.82 KCNH2 (0.61) KCNH2GRIN2BKDM4EHTR1ADRD2
SCHEMBL9562529 0.79 KCNH2 (0.57) KCNH2GRIN2BHTR2ATSHRGMNN
SCHEMBL9562326 0.79 KCNH2 (0.56) KCNH2GRIN2BKDM4EHTR1ADRD2
SCHEMBL9561898 0.77 KCNH2 (0.55) KCNH2GRIN2BHTR1ADRD2HTR2A
SCHEMBL9562497 0.76 KCNH2 (0.57) KCNH2GRIN2BHTR1ADRD2HTR2A
SCHEMBL10722357 0.76 KDM4E (0.49) GRIN2BKDM4ETSHRGMNNTP53
SCHEMBL10726153 0.75 KDM4E (0.39) GRIN2BKDM4EALDH1A1TSHRGMNN
SCHEMBL8439768 0.75 KCNH2 (0.54) KCNH2GRIN2BHTR1ADRD2HTR2A
SCHEMBL10724902 0.74 CCR3 (0.41) KCNH2GRIN2BKDM4EHTR1ADRD2
SCHEMBL8301971 0.74 KCNH2 (0.52) KCNH2GRIN2BHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0524846-A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-27 EP disclosed